Home Evogene

Evogene

In operation
IPO
AI Drug Discovery Service Provider

Basic Information

Evogene is dedicated to bridging the gap between the commercial product needs of the pharmaceutical and agrochemical industries and tailored computational innovations. Our unique approach holds the promise of transforming generative AI discoveries into practical and commercially valuable products. At the heart of Evogene lies ChemPass AI™, a proprietary generative AI technology engine capable of creating efficient, unique small molecules optimized for multiple key parameters, thereby increasing success rates while reducing time and costs.
Evogene Ltd.
Rehovot,CentralDistrict,Israel
101~500 people
January 01, 2002
info@evogene.com